Jim Simons Black Diamond Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 167,100 shares of BDTX stock, worth $424,434. This represents 0.0% of its overall portfolio holdings.

Number of Shares

167,100

Previous 79,900 109.14%

Holding current value

$424,434

Previous $123,000 236.59%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$1.25 - $2.59 $109,000 - $225,848	87,200 Added 109.14%	167,100 $414,000
Q1 2025 May 14, 2025	SELL	$1.55 - $2.73 $1.28 Million - $2.25 Million	-824,100 Reduced 91.16%	79,900 $123,000
Q4 2024 Feb 13, 2025	BUY	$2.14 - $4.17 $1.39 Million - $2.71 Million	650,200 Added 256.19%	904,000 $1.93 Million
Q3 2024 Nov 13, 2024	SELL	$4.2 - $6.58 $42,420 - $66,458	-10,100 Reduced 3.83%	253,800 $1.1 Million
Q2 2024 Aug 09, 2024	BUY	$4.65 - $7.39 $238,545 - $379,107	51,300 Added 24.13%	263,900 $1.23 Million
Q1 2024 May 13, 2024	SELL	$2.67 - $5.74 $634,926 - $1.36 Million	-237,800 Reduced 52.8%	212,600 $1.08 Million
Q4 2023 Feb 13, 2024	BUY	$1.77 - $3.03 $215,055 - $368,145	121,500 Added 36.94%	450,400 $1.27 Million
Q3 2023 Nov 14, 2023	BUY	$2.87 - $4.99 $310,534 - $539,918	108,200 Added 49.03%	328,900 $944,000
Q2 2023 Aug 11, 2023	BUY	$1.43 - $6.18 $4,576 - $19,776	3,200 Added 1.47%	220,700 $1.12 Million
Q1 2023 May 12, 2023	SELL	$1.35 - $3.14 $4,202 - $9,774	-3,113 Reduced 1.41%	217,500 $411,000
Q4 2022 Feb 13, 2023	BUY	$1.27 - $2.51 $3,699 - $7,311	2,913 Added 1.34%	220,613 $397,000
Q3 2022 Nov 14, 2022	SELL	$1.68 - $4.01 $91,227 - $217,751	-54,302 Reduced 19.96%	217,700 $368,000
Q2 2022 Aug 12, 2022	BUY	$1.5 - $3.63 $11,266 - $27,264	7,511 Added 2.84%	272,002 $669,000
Q1 2022 May 13, 2022	SELL	$2.66 - $5.61 $321,617 - $678,299	-120,909 Reduced 31.37%	264,491 $733,000
Q4 2021 Feb 11, 2022	BUY	$5.18 - $8.48 $2 Million - $3.27 Million	385,400 New	385,400 $2.05 Million
Q2 2021 Aug 13, 2021	SELL	$12.19 - $28.17 $226,734 - $523,962	-18,600 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$22.23 - $34.75 $413,478 - $646,350	18,600 New	18,600 $451,000
Q3 2020 Nov 13, 2020	SELL	$26.17 - $43.07 $693,688 - $1.14 Million	-26,507 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$22.3 - $44.8 $591,106 - $1.19 Million	26,507 New	26,507 $1.12 Million

Others Institutions Holding BDTX

# of Institutions

Shares Held

41.3M

Call Options Held

Put Options Held

View Full List

About Black Diamond Therapeutics, Inc.

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $92.3M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

More about BDTX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account